BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 33704530)

  • 21. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
    Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
    Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous remission of acute myeloid leukemia after discontinuation of lenalidomide.
    Kremer B; Tsai DE; Debonera F; Cohen PL; Schuster SJ
    Leuk Lymphoma; 2018 Mar; 59(3):743-745. PubMed ID: 28695787
    [No Abstract]   [Full Text] [Related]  

  • 23. What is the role of the bone marrow microenvironment in AML?
    Mulherkar N; Scadden DT
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101328. PubMed ID: 34865700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow.
    Bansal D; Vij K; Chang GS; Miller CA; DiPersio JF; Vij R; Heath SE; Westervelt P; Welch JS; Fehniger TA
    Haematologica; 2018 Jun; 103(6):e270-e273. PubMed ID: 29567774
    [No Abstract]   [Full Text] [Related]  

  • 25. Thalidomide for the treatment of acute myeloid leukemia.
    Steins MB; Bieker R; Padró T; Kessler T; Kienast J; Berdel WE; Mesters RM
    Leuk Lymphoma; 2003 Sep; 44(9):1489-93. PubMed ID: 14565649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.
    Kinoshita A; Miyachi H; Matsushita H; Yabe M; Taki T; Watanabe T; Saito AM; Tomizawa D; Taga T; Takahashi H; Matsuo H; Kodama K; Ohki K; Hayashi Y; Tawa A; Horibe K; Adachi S
    Br J Haematol; 2014 Oct; 167(1):80-6. PubMed ID: 25039450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
    Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
    Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
    Kogan AA; Lapidus RG; Baer MR; Rassool FV
    Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the bone marrow microenvironment in acute leukemia.
    Karantanou C; Godavarthy PS; Krause DS
    Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment.
    Becker PS
    ScientificWorldJournal; 2012; 2012():856467. PubMed ID: 22346731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.
    Devillier R; Gelsi-Boyer V; Brecqueville M; Carbuccia N; Murati A; Vey N; Birnbaum D; Mozziconacci MJ
    Am J Hematol; 2012 Jul; 87(7):659-62. PubMed ID: 22535592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients.
    Xu XQ; Wang JM; Gao L; Qiu HY; Chen L; Jia L; Hu XX; Yang JM; Ni X; Chen J; Lü SQ; Zhang WP; Song XM
    Am J Hematol; 2014 Sep; 89(9):874-81. PubMed ID: 24861848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches.
    Menter T; Tzankov A
    Front Immunol; 2022; 13():811144. PubMed ID: 35273598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.
    Ossenkoppele GJ; Breems DA; Stuessi G; van Norden Y; Bargetzi M; Biemond BJ; A von dem Borne P; Chalandon Y; Cloos J; Deeren D; Fehr M; Gjertsen B; Graux C; Huls G; Janssen JJJW; Jaspers A; Jongen-Lavrencic M; de Jongh E; Klein SK; van der Klift M; van Marwijk Kooy M; Maertens J; Michaux L; van der Poel MWM; van Rhenen A; Tick L; Valk P; Vekemans MC; van der Velden WJFM; de Weerdt O; Pabst T; Manz M; Löwenberg B;
    Leukemia; 2020 Jul; 34(7):1751-1759. PubMed ID: 32020044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
    Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
    Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts.
    Dembitz V; Lalic H; Kodvanj I; Tomic B; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
    BMC Cancer; 2020 Nov; 20(1):1090. PubMed ID: 33176741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.
    Cross AH; Goorha RM; Nuss R; Behm FG; Murphy SB; Kalwinsky DK; Raimondi S; Kitchingman GR; Mirro J
    Blood; 1988 Aug; 72(2):579-87. PubMed ID: 3261183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia regulates proliferation of acute myeloid leukemia and sensitivity against chemotherapy.
    Drolle H; Wagner M; Vasold J; Kütt A; Deniffel C; Sotlar K; Sironi S; Herold T; Rieger C; Fiegl M
    Leuk Res; 2015 Jul; 39(7):779-85. PubMed ID: 25982178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes.
    Ikegawa S; Doki N; Kurosawa S; Yamaguchi T; Sakaguchi M; Harada K; Yamamoto K; Hino Y; Shingai N; Senoo Y; Watanabe K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Leuk Lymphoma; 2016; 57(1):76-80. PubMed ID: 26084204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the in vivo characteristics of acute myeloid leukemia cells behavior by intravital imaging.
    Duarte D; Amarteifio S; Ang H; Kong IY; Ruivo N; Pruessner G; Hawkins ED; Lo Celso C
    Immunol Cell Biol; 2019 Feb; 97(2):229-235. PubMed ID: 30422351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.